A phase II study of high-dose 24 hour continuous infusion 5-FU and leucovorin and low-dose PALA for patients with advanced pancreatic adenocarcinoma: A Southwest Oncology Group Study
Robert P. Whitehead, Jacqueline K. Benedetti, James L. Abbruzzese, Bach Ardalan, J. Wendall Goodwin, Stanley P. Balcerzak, Wolfram E. Samlowski, Heinz-Josef Lenz, John S. MacdonaldVolume:
22
Language:
english
Pages:
7
DOI:
10.1023/b:drug.0000026261.76197.54
Date:
August, 2004
File:
PDF, 71 KB
english, 2004